Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--MPLX Raises Quarterly Dividend by 12.5% to $1.0765 a Unit, Payable Nov. 14 to Unitholders of Record as of Nov. 7
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--MPLX Raises Quarterly Dividend by 12.5% to $1.0765 a Unit, Payable Nov. 14 to Unitholders of Record as of Nov. 7
Oct 28, 2025 8:09 AM
10:47 AM EDT, 10/28/2025 (MT Newswires) --
Price: 50.71, Change: -0.12, Percent Change: -0.23
Previous page:
Mike Lynch's estate refused permission to appeal in UK HP-Autonomy case
Next page:
Yimutian Inc. Provides 2026 Strategic Update: Financing on Track, Management to Purchase No Less Than US$3 Million in Company Shares, Full-Year Revenue Expected to Reach RMB 1 Billion
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Mike Lynch's estate refused permission to appeal in UK HP-Autonomy case
Mar 24, 2026
LONDON, March 24 (Reuters) - The estate of late British tech tycoon Mike Lynch was on Tuesday refused permission to appeal a ruling by London's High Court that he was liable to Hewlett Packard Enterprise ( HPE ) over its acquisition of his firm Autonomy. The U.S. technology giant Hewlett Packard ( HPE ) is seeking damages from the estate...
Yimutian Inc. Provides 2026 Strategic Update: Financing on Track, Management to Purchase No Less Than US$3 Million in Company Shares, Full-Year Revenue Expected to Reach RMB 1 Billion
Mar 24, 2026
BEIJING, March 24, 2026 (GLOBE NEWSWIRE) -- Yimutian Inc. ( YMT ) (the Company) today issued a strategic update to investors and market participants, outlining the Company's capital plan, equity commitments, and financial outlook for 2026. Following a management meeting convened on March 20, 2026, the Board and senior management are setting out, in plain terms, the actions the Company...
Form 8.3
Mar 24, 2026
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...
Gilead Sciences to Acquire Ouro Medicines in Up to $2.18 Billion Deal
Mar 24, 2026
06:40 AM EDT, 03/24/2026 (MT Newswires) -- Gilead Sciences ( GILD ) has agreed to acquire autoimmune disease therapy developer Ouro Medicines for up to $2.18 billion, while the biopharmaceutical firm is in collaboration talks with Galapagos (GLPG) on the assets from the proposed deal. Gilead will pay $1.68 billion in cash for Ouro Medicines as well as up to...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP